Synonyms:dihydroergotamine, 9,10-Dihydroergotamine, 511-12-6, Dihidroergotamina, Dihydroergotaminum, Dihydroergotaminum [INN-Latin], Dihidroergotamina [INN-Spanish], Neomigran, Dehydroergotamine, MAP0004, Dihydroergotamine (INN), Dihydroergotamine [INN], MAP-0004, CHEMBL1732, CHEBI:4562, DTXSID6045614, 436O5HM03C, Ergotamine, 9,10-dihydro-, NCGC00017400-05, Levadex, Diidroergotamina, 5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman, Diidroergotamina [DCIT], 9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione, DTXCID4025614, 9,10-dihydro-ergotamine, DHE, Neomigran (TN), (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide, (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, CAS-511-12-6, EINECS 208-123-3, BRN 5720196, Dihydroergotamine [INN:BAN], UNII-436O5HM03C, NCGC00017400-10, MAP 0004, Spectrum_001057, Spectrum2_001188, Spectrum3_000395, Spectrum4_000958, Spectrum5_000905, Lopac0_000357, SCHEMBL44931, BSPBio_002209, GTPL121, KBioGR_001576, KBioSS_001537, BIDD:GT0120, DIHYDROERGOTAMINE [MI], DivK1c_000592, SPBio_001235, DIHYDROERGOTAMINE [VANDF], KBio1_000592, KBio2_001537, KBio2_004105, KBio2_006673, KBio3_001429, DIHYDROERGOTAMINE [MART.], NINDS_000592, DIHYDROERGOTAMINE [WHO-DD], 7-Methyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((2R,5S,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-octahydro-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-amide, Tox21_110821, BDBM50295557, Tox21_110821_1, CCG-204452, DB00320, SDCCGSBI-0050345.P005, (10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman, IDI1_000592, NCGC00017400-06, NCGC00017400-07, NCGC00017400-08, Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-, SBI-0050345.P004, C07798, D07837, AB00053458_03, EN300-26508628, Q421336, BRD-K72166146-066-02-1, BRD-K72166146-066-03-9, (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide, (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide, (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide, 2GM, 7-Methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-octahydro-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-amide
Pubchem:PUBCHEM:10531
Id:c1e3df59-5d19-57e3-990d-cecea2d15994
Description:nan
